Prednisolone and Kanamycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prednisolone (prednisolone) and Kanamycin (kanamycin sulfate). Common drug interactions include diarrhoea among females and granulocytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Prednisolone and Kanamycin. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Prednisolone?

Prednisolone has active ingredients of prednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 212,675 Prednisolone users. Check the latest studies of Prednisolone.

What is Kanamycin?

Kanamycin has active ingredients of kanamycin sulfate. eHealthMe is studying from 934 Kanamycin users. Check the latest studies of Kanamycin.



On Jul, 11, 2026

25 people who take Prednisolone and Kanamycin together, and have interactions are studied.

Prednisolone and Kanamycin drug interactions.

What are the common drug interactions of Prednisolone and Kanamycin, by gender? *:

female:

  1. Diarrhoea
  2. Cytomegalovirus infection
  3. Cholangitis (infection of the bile duct)
  4. Periodontitis (inflammation of the tissue around the teeth)
  5. Platelet count decreased
  6. Posterior capsule opacification
  7. Splenic artery aneurysm (enlargement of splenic artery)
  8. Vascular pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity)
  9. Aspartate aminotransferase increased
  10. Blepharitis (chronic inflammation of the eyelid)

male:

  1. Granulocytopenia (lack of granulocyte)
  2. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  3. Hemianopia homonymous (visual field defect involving either the two right or the two left halves of the visual fields of both eyes)
  4. Pulmonary mycosis (lung infection caused by yeast-like fungi)
  5. Pyrexia (fever)
  6. Rash
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Brain abscess
  9. Fistula (an abnormal connection or passageway between two)
  10. Fungal abscess central nervous system (collection of pus in brain by result of fungal infection)

What are the common drug interactions of Prednisolone and Kanamycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Drug resistance (reduction in effectiveness of a drug)
  2. Headache (pain in head)
  3. Hemianopia homonymous (visual field defect involving either the two right or the two left halves of the visual fields of both eyes)
  4. Pulmonary mycosis (lung infection caused by yeast-like fungi)
  5. Pyrexia (fever)
  6. Brain abscess
  7. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  8. Fungal abscess central nervous system (collection of pus in brain by result of fungal infection)
  9. Fungal infection
  10. Nuclear magnetic resonance imaging brain

10-19:

  1. Granulocytopenia (lack of granulocyte)
  2. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  3. Budd-chiari syndrome (problem that results from blood clotting in the veins flowing out of the liver (hepatic veins))

20-29:

  1. Mycobacterium abscessus infection (rapid growing bacterial infection)
  2. Pathogen resistance

30-39:

  1. Alanine aminotransferase increased
  2. Alopecia (absence of hair from areas of the body)
  3. Aspartate aminotransferase increased
  4. Blood lactate dehydrogenase increased
  5. C-reactive protein increased
  6. Erythema (redness of the skin)
  7. Face oedema (swelling of face)
  8. Human herpesvirus 6 infection
  9. Lymphadenopathy (disease or enlargement of lymph nodes)
  10. Lymphocyte count increased

40-49:

  1. Anaemia (lack of blood)
  2. Aspartate aminotransferase increased
  3. Blood bilirubin increased
  4. Gamma-glutamyltransferase increased
  5. Autoimmune hepatitis
  6. Haematocrit decreased
  7. Haemoglobin decreased
  8. Hepatic failure (liver failure)
  9. Red blood cell count decreased

50-59:

  1. Cytomegalovirus infection
  2. Cholangitis (infection of the bile duct)
  3. Splenic artery aneurysm (enlargement of splenic artery)
  4. Vascular pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity)
  5. Osteoporosis (bones weak and more likely to break)
  6. Atypical mycobacterial infection (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis)
  7. Rash
  8. Acute respiratory distress syndrome
  9. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

60+:

  1. Diarrhoea
  2. Periodontitis (inflammation of the tissue around the teeth)
  3. Hepatopulmonary syndrome (syndrome of shortness of breath and hypoxemia (low oxygen levels in the blood of the arteries) in the lungs of patients with liver disease)
  4. Retinal haemorrhage (bleeding from retina)
  5. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose)
  6. Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
  7. Dental caries
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  10. Fistula (an abnormal connection or passageway between two)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 24.00%
  2. Diarrhea: 5 people, 20.00%
  3. Hepatitis B: 4 people, 16.00%
  4. Periarthritis (inflammation of the external coats of an artery and of the tissues around the artery): 4 people, 16.00%
  5. Osteoporosis (bones weak and more likely to break): 4 people, 16.00%
  6. Nausea (feeling of having an urge to vomit): 4 people, 16.00%
  7. Insomnia (sleeplessness): 4 people, 16.00%
  8. High Blood Pressure: 4 people, 16.00%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 16.00%
  10. Gastritis (inflammation of stomach): 4 people, 16.00%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisolone and Kanamycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prednisolone and Kanamycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kanamycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prednisolone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kanamycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on prednisolone and kanamycin sulfate (the active ingredients of Prednisolone and Kanamycin, respectively), and Prednisolone and Kanamycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: